


Mirendil
Trains models meant to do AI research themselves and builds a platform around them, so labs in drug discovery, chemistry or biology can do frontier AI work without becoming AI labs.
Money and evidence
Latest round, Round (unnamed) (in talks), 2026-09-22: the record then held no research entry for the company. The first research entry is dated 2026-10-21; the highest level so far is 2 (Computed).
Rounds and research, on one timeline
- 2026-10-21Research
Level 2 · Computed
Mirendil says one researcher working with AI agents pretrained Mirendil-Base, a coding model of 100B to 500B parameters, in 3.5 months for under $10M
Pretraining a competitive base model has taken a team of specialists in architecture, data and chips. If one person directing agents can do it, the scarce inputs become compute and judgment, and a group whose expertise is in its own science, such as a robotics lab or a hospital, could train a model on its own data. It is the first result from a company that raised on the pitch that labs using AI in biology or chemistry should not have to become AI labs.
- 2026-09-22Round (unnamed)In talksRound
up to $1B$5B post · stated by Bloomberg
For: launching its own model and training future ones
Models and platform
Kleiner in talks to lead, a16z in discussions; Mirendil declined to comment.
Lead · Kleiner Perkins ✓Andreessen Horowitz ✓
Reported by Bloomberg · finance.yahoo.com ↗On the timeline →
- 2026-06-24SeedRound
$200M$1B · stated by Tech Funding News
Not stated
a16z announced it was leading the seed without stating the amount.
Co-lead · Andreessen Horowitz ✓Co-lead · Kleiner Perkins ✓NVIDIA ✓
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
On the investors' own sites
Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.
- Andreessen HorowitzSeeda16z.com ↗
- Kleiner Perkins2026, Earlykleinerperkins.com ↗
- NVIDIAnvidia.com ↗
Its investors also backed
Other companies on this page whose rounds name the same investor.
- NVentures (NVIDIA)EvolutionaryScale, Generate:Biomedicines, Iambic Therapeutics, Inceptive, Genesis Molecular AI (formerly Genesis Therapeutics), Terray Therapeutics, Lila Sciences, Periodic Labs, Radical AI, Achira, CuspAI, Orbital Industries, Basecamp Research, Relation Therapeutics, Superluminal Medicines, Ricursive Intelligence, AMI Labs, Recursive Superintelligence, Inherent, Generalist AI, Ineffable Intelligence
- a16zBigHat Biosciences, Inceptive, Genesis Molecular AI (formerly Genesis Therapeutics), Periodic Labs
- Kleiner PerkinsChai Discovery, Discovery Loop, CuspAI